ICD-10 D3A
Non-Billable HeaderBenign neuroendocrine tumors
About ICD-10-CM D3A
ICD-10-CM code D3A represents Benign neuroendocrine tumors. This is a non-billable header code in the Neoplasms chapter (block D3A). The 2026 edition of ICD-10-CM D3A became effective on October 1, 2025. Non-billable codes cannot be used as a primary or secondary diagnosis on a claim, use a more specific child code instead.
Type 2 Excludes
Not included here, the excluded code is not part of D3A, but a patient may have both conditions at the same time. Both codes may be coded together when applicable.
- benign pancreatic islet cell tumors (D13.7)
Use Additional Code
When coding D3A, also report these additional codes when applicable.
- code to identify any associated endocrine syndrome, such as:
- carcinoid syndrome (E34.00)
Coding Notes
Code Also
- any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)
Medicare LCD Coverage for D3A
Local Coverage Determinations (LCDs) from CMS MACs that list D3A as a covered diagnosis.
This doesn't mean the code isn't covered, it means no MAC has issued a Local Coverage Determination naming this specific code. Coverage may still apply under National Coverage Determinations or general medical-necessity rules.
Commercial Payer Coverage
Coverage policies from major commercial payers referencing D3A.
Our payer policy database covers Aetna, Cigna, Anthem, BCBS, Humana, and Medicare Advantage plans, but D3A doesn't currently appear in any indexed policy. The code may still be covered under standard plan benefits.
CPT Codes Commonly Billed with D3A
Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.
We don't have CPT pairings indexed for this specific code yet. Use the CPT search above to find common procedures, or check your payer's published medical policy for code-specific guidance.
Codes Adjacent To D3A
Other codes in section D3A (Benign neuroendocrine tumors).
ICD-10 D3A, Billing FAQ
Is ICD-10 code D3A billable? +
No, D3A is a non-billable header code. Use a more specific child code from block D3A when submitting claims.
What codes are Type 2 Excludes for D3A? +
Type 2 Excludes (may be coded together when both conditions exist): benign pancreatic islet cell tumors (D13.7)
Get the full PayerReady toolkit
Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.
Start free →Run this code through our claim audit tool
Check NCCI bundling, MUE limits, and modifier logic before submission.
Try the auditor →Did this page help?
Quick signal so we know what to improve.
If you want a code reference page that doesn't exist yet, email coding@payerready.com.
Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.
Reviewed by the PayerReady Medical Coding Team
Verified against the CMS 2026 code set on June 1, 2026.
Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team